Edwards Lifesciences KUV 2024

Edwards Lifesciences Aktienanalyse

Šta radi Edwards Lifesciences?

Edwards Lifesciences Corp is a globally operating company in the field of medical technology, specializing in the development, production, and distribution of products for the treatment of heart diseases and critical illnesses. The company was founded in California in 1958 and is now one of the leading companies in the field of modern heart valve technology. The history of Edwards Lifesciences begins with its founding by Miles "Lowell" Edwards and his longtime employee Dr. Albert Starr. They recognized the need for a less invasive and more effective alternative to heart valves than the existing surgical methods. They received their first patent in 1960 and performed their first successful heart valve operation on a sheep in the same year. The first surgeries on humans took place in 1962. Edwards Lifesciences quickly expanded in the US and internationally. The business model of Edwards Lifesciences focuses on three business areas: "Transcatheter Heart Valve Systems," "Surgical Heart Valve Therapy," and "Critical Care." Each area is focused on a specific range of products and is supported by its own team of professionals. The "Transcatheter Heart Valve Systems" area has become the most important division of Edwards Lifesciences. This novel technology enables the implantation of an artificial heart valve system through minimally invasive surgical methods, without the need for an open procedure. The system consists of a foldable heart valve made of animal tissue or artificial material, which is inserted into the damaged heart through a catheter. This method is applicable to a wide range of patients and has become an important tool in the treatment of heart diseases. The "Surgical Heart Valve Therapy" business area includes implantable mechanical and biological heart valves for open surgical procedures. Edwards Lifesciences develops innovative products to meet the needs of surgical patients and doctors. The third business area, "Critical Care," offers instruments and technologies for the critical medical care of patients in intensive care units and emergency departments. The company manufactures collagen matrix products for wound care, catheter monitoring systems, and patient monitoring devices to detect potential life-threatening complications early. Over the years, Edwards Lifesciences has introduced numerous innovative products to the market that are used in medical practice. The Edwards SAPIEN Transcatheter Heart Valve System was approved in Europe in 2011 and in the US in 2012 and has since improved the lives of tens of thousands of patients. With new technologies such as the Edwards SAPIEN 3 and SAPIEN 3 Ultra platforms, the company is constantly striving to increase the effectiveness and safety of heart disease treatment. Edwards Lifesciences is headquartered in Irvine, California, and is a multinational company with locations in North America, Europe, India, and Asia. The company currently employs approximately 14,000 people worldwide and is an important pillar of the medical community. Answer: Edwards Lifesciences Corp is a global medical technology company specializing in the development, production, and distribution of products for the treatment of heart diseases and critical illnesses. It is a leader in modern heart valve technology. Edwards Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

KUV у детаљу

Otključavanje KUV-a kompanije Edwards Lifesciences

Koeficijent cene i prometa (KUV) kompanije Edwards Lifesciences je važan finansijski pokazatelj koji meri tržišnu vrednost kompanije u odnosu na njen ukupni prihod od prodaje. Izračunava se deljenjem tržišne kapitalizacije kompanije sa njenim ukupnim prihodom od prodaje za određeni vremenski period. Niži KUV može ukazivati na to da je kompanija podcenjena, dok viši koeficijent može ukazivati na prekomernu vrednost.

Godišnja poređenja KUV-a

Poređenje KUV-a kompanije Edwards Lifesciences na godišnjem nivou pruža uvid u to kako tržište percipira vrednost kompanije u odnosu na njene prodaje. Rastući koeficijent tokom vremena može ukazivati na rastuće poverenje investitora, dok opadajući trend može odražavati zabrinutost u vezi sposobnosti generisanja prihoda kompanije ili tržišnih uslova.

Utjecaj na investicije

KUV je ključan za investitore prilikom procene akcija kompanije Edwards Lifesciences. Pruža uvid u efikasnost kompanije u generisanju prihoda i njenom tržišnom vrednovanju. Investitori koriste ovaj koeficijent za poređenje sličnih kompanija unutar iste industrije, i pomaže u izboru akcija koje nude najbolju vrednost za investiciju.

Interpretacija fluktuacija KUV-a

Promene u KUV-u kompanije Edwards Lifesciences mogu proisteći iz promena u ceni akcija, prihodima od prodaje ili oboje. Razumevanje ovih fluktuacija je ključno za investitore za procenu trenutne vrednosti kompanije i potencijalnog budućeg rasta, te usmeravanje investicionih strategija u skladu s tim.

Često postavljana pitanja o Edwards Lifesciences akciji

Koje je odnos cene i zarade akcija od Edwards Lifesciences?

Odnos cene i dobiti akcija Edwards Lifesciences trenutno iznosi 7,84.

Kako se odnos cene i zarade akcija Edwards Lifesciences promenio u poređenju sa prošlom godinom?

Odnošaj cene i zarade kompanije Edwards Lifesciences u poređenju sa prošlom godinom porastao je za -9,36% opao.

Koje posledice visok odnos cene i zarade ima za investitore?

Visok odnos cene i dobiti ukazuje na to da su akcije kompanije relativno skupe i da investitori možda ostvare manji prinos.

Šta znači nizak odnos cene i zarade?

Nisko odnos cene i zarade znači da je akcija kompanije relativno jeftina i investitori mogu potencijalno ostvariti viši prinos.

Da li je odnos cene i dobiti akcija kompanije Edwards Lifesciences visok u poređenju sa drugim kompanijama?

Da, odnos cene i zarade (P/E) kompanije Edwards Lifesciences je visok u poređenju sa drugim kompanijama.

Kako povećanje odnosa cene i zarade od Edwards Lifesciences utiče na kompaniju?

Povećanje odnosa cena-dobit od Edwards Lifesciences bi dovelo do veće tržišne kapitalizacije preduzeća, što bi pak dovelo do veće procene vrednosti preduzeća.

Kako smanjenje odnosa cene i zarade od Edwards Lifesciences utiče na kompaniju?

Smanjenje odnosa cene i zarade od Edwards Lifesciences dovelo bi do niže tržišne kapitalizacije kompanije, što bi zauzvrat dovelo do niže vrednosti preduzeća.

Koji su neki faktori koji utiču na odnos cene i zarade od Edwards Lifesciences?

Neki faktori koji utiču na odnos cene i zarade Edwards Lifesciences su rast kompanije, finansijska situacija kompanije, razvoj industrije i opšta ekonomska klima.

Kolika je dividenda koju isplaćuje Edwards Lifesciences?

U poslednjih 12 meseci, Edwards Lifesciences je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Edwards Lifesciences će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Edwards Lifesciences?

Dividendski prinos od Edwards Lifesciences trenutno iznosi .

Kada Edwards Lifesciences isplaćuje dividendu?

Edwards Lifesciences isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Edwards Lifesciences?

Edwards Lifesciences je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Edwards Lifesciences?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Edwards Lifesciences?

Edwards Lifesciences se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Edwards Lifesciences kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Edwards Lifesciences od 27. 4. 2024. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 27. 4. 2024..

Kada je Edwards Lifesciences poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 27. 4. 2024..

Kolika je bila dividenda od Edwards Lifesciences u godini 2023?

U godini 2023 kompanija Edwards Lifesciences je isplatila 0 USD kao dividende.

U kojoj valuti Edwards Lifesciences isplaćuje dividendu?

Dividende od Edwards Lifesciences se isplaćuju u USD.